Updates from The Motley Fool

Latest updates on PDL BioPharma from Fool.com.


Stock Performance

PDLI vs. S&P 500 | 2 Year Performance
PDLI 1-Day Stock Chart
PDLI 5-Day Stock Chart
PDLI 1-Month Stock Chart
PDLI 3-Month Stock Chart
PDLI 6-Month Stock Chart
PDLI 1-Year Stock Chart
PDLI 2-Year Stock Chart
PDLI 5-Year Stock Chart
View Interactive PDLI Charts
Sponsored by

Key Data Points

Primary metrics and data points about PDL BioPharma.
Current Price: $3.28
Prev Close: $3.33
Open: $3.32
Bid: $3.27
Ask: $3.28
Day's Range: $3.27 - $3.36
52wk Range: $2.58 - $6.83
Volume: 420,357
Avg Vol 1,393,670
Market Cap: $535.71M
P/E (ttm): 1.78
EPS (ttm): $1.87
Div & Yield: $0.60 (6.0%)

Company Rating

What our community thinks about PDL BioPharma.
CAPS Rating 4 out of 5
 
846 Outperform
44 Underperform
CAPS All Stars
 
161 Outperform
11 Underperform

How do you think PDL BioPharma will perform against the market?



You pick for PDL BioPharma is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John P. McLaughlin, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for PDL BioPharma.

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers